Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management. 2012

Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.

OBJECTIVE Primary liver cancer (PLC) presenting as pyogenic liver abscess (PLA) is potentially life-threatening, but has been occasionally reported, especially for cholangiocarcinoma. METHODS Medical records of nine patients who presented as PLA, but were eventually confirmed as hepatocellular carcinoma (HCC; n = 5) or intrahepatic cholangiocarcinoma (IHCC; n = 4), from September 1997 through April 2011, were retrospectively reviewed. RESULTS Presenting symptoms included fever, chills, right-upper-quadrant abdominal pain, nausea, vomiting, weight loss, and diarrhea. Physical signs included tenderness in the right-upper-quadrant abdomen, jaundice, and ascites. With the exception of elevated alpha-fetoprotein (AFP) in HCC patients and elevated carbohydrate antigen 19-9 (CA19-9) in IHCC patients, lab results were not significantly different between these nine patients and PLA patients. All the nine patients underwent invasive treatment in addition to antibiotics. CONCLUSIONS Elevated AFP and CA19-9 could suggest HCC and IHCC in patients with symptoms/signs typical of PLA. Contrast-enhanced computed tomography could be helpful in patients with normal AFP and CA19-9. Making an accurate and early diagnosis and seizing the opportunity of surgery are essential to improve the management strategies of patients with PLC mimicking PLA.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins
D046290 Liver Abscess, Pyogenic Single or multiple areas of PUS due to bacterial infection within the hepatic parenchyma. It can be caused by a variety of BACTERIA, local or disseminated from infections elsewhere such as in APPENDICITIS; CHOLECYSTITIS; PERITONITIS; and after LIVER TRANSPLANTATION. Pyogenic Hepatic Abscess,Pyogenic Liver Abscess,Abscess, Pyogenic Hepatic,Abscess, Pyogenic Liver,Abscesses, Pyogenic Hepatic,Abscesses, Pyogenic Liver,Hepatic Abscess, Pyogenic,Hepatic Abscesses, Pyogenic,Liver Abscesses, Pyogenic,Pyogenic Hepatic Abscesses,Pyogenic Liver Abscesses
D018395 CA-19-9 Antigen Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors. 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine,Antigen CA-19-9,Gastrointestinal Cancer Antigen,Sialyl Le(a),Sialyl Lewis A,Sialyl Lewis A Antigen,Sialyl Lewis(a) Tetrasaccharide,CA 19-9 Antigen,CA 19.9 Antigen,NAG-1,3-F-1,4-GN,Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc,alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alpha-L-Fuc-(1-4))-beta-D-GlcNAc,A, Sialyl Lewis,Antigen CA 19 9,Antigen, CA 19-9,Antigen, CA 19.9,Antigen, CA-19-9,CA 19 9 Antigen,CA-19-9, Antigen,Cancer Antigen, Gastrointestinal,Lewis A, Sialyl

Related Publications

Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
May 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
December 2008, Gastroenterologie clinique et biologique,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
December 1993, The American journal of gastroenterology,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
January 2017, The Korean journal of internal medicine,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
June 2021, Hepatology international,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
May 2018, Medicine,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
May 2007, Revista espanola de enfermedades digestivas,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
January 1979, Postgraduate medical journal,
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
January 1987, Deutsche medizinische Wochenschrift (1946),
Cong Li, and Guangbing Li, and Ruoyu Miao, and Xin Lu, and Shouxian Zhong, and Xinting Sang, and Yilei Mao, and Haitao Zhao
January 1982, The British journal of surgery,
Copied contents to your clipboard!